These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 18673269)
1. Development of selective high affinity antagonists, agonists, and radioligands for the P2Y1 receptor. Houston D; Costanzi S; Jacobson KA; Harden TK Comb Chem High Throughput Screen; 2008 Jul; 11(6):410-9. PubMed ID: 18673269 [TBL] [Abstract][Full Text] [Related]
2. Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. Costanzi S; Mamedova L; Gao ZG; Jacobson KA J Med Chem; 2004 Oct; 47(22):5393-404. PubMed ID: 15481977 [TBL] [Abstract][Full Text] [Related]
3. 2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists. Kim HS; Ohno M; Xu B; Kim HO; Choi Y; Ji XD; Maddileti S; Marquez VE; Harden TK; Jacobson KA J Med Chem; 2003 Nov; 46(23):4974-87. PubMed ID: 14584948 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y(1) receptor ligands. Nandanan E; Jang SY; Moro S; Kim HO; Siddiqui MA; Russ P; Marquez VE; Busson R; Herdewijn P; Harden TK; Boyer JL; Jacobson KA J Med Chem; 2000 Mar; 43(5):829-42. PubMed ID: 10715151 [TBL] [Abstract][Full Text] [Related]
5. 2-Chloro N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate is a selective high affinity P2Y(1) receptor antagonist. Boyer JL; Adams M; Ravi RG; Jacobson KA; Harden TK Br J Pharmacol; 2002 Apr; 135(8):2004-10. PubMed ID: 11959804 [TBL] [Abstract][Full Text] [Related]
6. Ribose modified nucleosides and nucleotides as ligands for purine receptors. Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists. Nandanan E; Camaioni E; Jang SY; Kim YC; Cristalli G; Herdewijn P; Secrist JA; Tiwari KN; Mohanram A; Harden TK; Boyer JL; Jacobson KA J Med Chem; 1999 May; 42(9):1625-38. PubMed ID: 10229631 [TBL] [Abstract][Full Text] [Related]
8. Acyclic analogues of deoxyadenosine 3',5'-bisphosphates as P2Y(1) receptor antagonists. Kim YC; Gallo-Rodriguez C; Jang SY; Nandanan E; Adams M; Harden TK; Boyer JL; Jacobson KA J Med Chem; 2000 Feb; 43(4):746-55. PubMed ID: 10691699 [TBL] [Abstract][Full Text] [Related]
9. Agonists and antagonists for P2 receptors. Jacobson KA; Costanzi S; Joshi BV; Besada P; Shin DH; Ko H; Ivanov AA; Mamedova L Novartis Found Symp; 2006; 276():58-68; discussion 68-72, 107-12, 275-81. PubMed ID: 16805423 [TBL] [Abstract][Full Text] [Related]
10. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors. Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592 [TBL] [Abstract][Full Text] [Related]
11. Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog. Chhatriwala M; Ravi RG; Patel RI; Boyer JL; Jacobson KA; Harden TK J Pharmacol Exp Ther; 2004 Dec; 311(3):1038-43. PubMed ID: 15345752 [TBL] [Abstract][Full Text] [Related]